Concepta PLC (LON:FRI) had its target price dropped by investment analysts at Liberum Capital from GBX 1,250 ($16.14) to GBX 850 ($10.98) in a report issued on Thursday, StockTargetPrices.com reports. The brokerage currently has a “buy” rating on the stock.

Several other analysts have also commented on FRI. FinnCap reiterated a “corporate” rating and issued a GBX 500 ($6.46) price target on shares of Concepta PLC in a research report on Thursday, June 22nd. Numis Securities Ltd upgraded shares of Concepta PLC to an “add” rating and raised their target price for the stock from GBX 300 ($3.87) to GBX 466 ($6.02) in a research report on Thursday, June 22nd. Finally, Peel Hunt restated a “buy” rating and set a GBX 120 ($1.55) target price on shares of Concepta PLC in a research report on Monday, September 4th.

ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/10/liberum-capital-cuts-concepta-plc-fri-price-target-to-gbx-850.html.

Concepta PLC Company Profile

Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. The Company’s portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.

Stock Target Prices

Receive News & Ratings for Concepta PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concepta PLC and related companies with MarketBeat.com's FREE daily email newsletter.